ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
5.46
+0.34 (6.64%)
At close: Mar 27, 2024, 4:00 PM
5.31
-0.15 (-2.75%)
Pre-market: Mar 28, 2024, 6:32 AM EDT

ImmunityBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Cash & Equivalents
265.45104.64181.134.9215.5116.8223.878.08175.9159.1
Upgrade
Short-Term Investments
1.012.54136.0261.1536.1458.05104.28190.84118.310
Upgrade
Cash & Cash Equivalents
266.46107.18317.1296.0651.6574.87128.15198.92294.2259.1
Upgrade
Cash Growth
148.60%-66.20%230.12%85.98%-31.01%-41.58%-35.58%-32.39%397.80%16786.86%
Upgrade
Receivables
2.021.891.332000.151.090.220
Upgrade
Other Current Assets
25.631.515.913.654.1113.94.155.143.110.27
Upgrade
Total Current Assets
294.08140.58334.35111.7155.7688.77132.46205.15297.5459.37
Upgrade
Property, Plant & Equipment
182.63189.45119.1790.6872.2376.8976.7318.915.520.21
Upgrade
Long-Term Investments
7.777.4713.9817.5310.7514.238.187.5755.140
Upgrade
Goodwill and Intangibles
17.09201.421.4600.572.835.097.290
Upgrade
Other Long-Term Assets
2.884.86004.391.530.330.791.360.41
Upgrade
Total Long-Term Assets
210.37221.78134.56109.6787.3793.18117.98112.3569.310.62
Upgrade
Total Assets
504.45362.36468.91221.38143.12181.95250.44317.5366.8560
Upgrade
Accounts Payable
10.3324.4915.3626.352.244.498.235.83.441.13
Upgrade
Deferred Revenue
00000000.190.230.52
Upgrade
Current Debt
5.24434.55302.255.023.2100000
Upgrade
Other Current Liabilities
42.7141.8351.3936.776.1222.7712.646.572.480.23
Upgrade
Total Current Liabilities
58.28500.8636968.1311.5627.2620.8712.556.151.88
Upgrade
Long-Term Debt
876.89289.22343.42270.5310.895.951.742.0300
Upgrade
Other Long-Term Liabilities
155.2122.090.411.2102.748.999.54.710.52
Upgrade
Total Long-Term Liabilities
1,032311.32343.83271.7410.898.6810.7311.534.710.52
Upgrade
Total Liabilities
1,090812.18712.82339.8722.4435.9431.624.0810.852.41
Upgrade
Total Debt
882.14723.77645.66275.5514.095.951.742.0300
Upgrade
Debt Growth
21.88%12.10%134.32%1855.48%137.02%241.47%-14.02%---
Upgrade
Retained Earnings
-2,961.68-2,378.49-1,961.92-1,615.13-662.19-594.98-498.71-387.06-250.38-13.57
Upgrade
Comprehensive Income
0.010.1800.12-0.11-0.27-0.38-0.28-0.190
Upgrade
Shareholders' Equity
-586.99-447.33-242.17-119.81120.68146.01218.84293.4235657.59
Upgrade
Net Cash / Debt
-615.68-616.59-328.55-179.4937.5668.93126.41196.9294.2259.1
Upgrade
Net Cash / Debt Growth
-----45.51%-45.47%-35.80%-33.08%397.80%-
Upgrade
Net Cash Per Share
-1.21-1.54-0.84-0.480.100.871.572.404.117.17
Upgrade
Working Capital
235.8-360.28-34.6543.5844.261.51111.59192.59291.3957.49
Upgrade
Book Value Per Share
-1.15-1.12-0.62-0.320.331.842.723.584.986.98
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).